Direct interferon-gamma-mediated protection caused by a recombinant coxsackievirus B3.
Coxsackievirus B3 (CVB3) is one of the most important causes of viral myocarditis. Cytokines are involved in the control of CVB3 replication and pathogenesis. Local expression of specific cytokines by recombinant CVB3 confers prevention of virus-caused myocarditis. Expression of IFN-gamma by CVB3(IFN-gamma) protected BALB/c and C57BL/6 mice when the lethal infection with the highly pathogenic CVB3H3 variant was given directly after or prior to CVB3(IFN-gamma) inoculation by decreasing the viral load and spread as well as tissue destruction. This direct effect was not restricted to the homologous virus. In vitro, cocultivation of CVB3(IFN-gamma)-infected cells induced a reduction of CVB3H3 replication and virus-induced cytopathogenicity.
Henke
Andreas
A
Institute of Virology and Antiviral Therapy, Medical Center, Friedrich Schiller University, Winzerlaer Strasse 10, D-07745 Jena, Germany. i6hean@rz.uni-jena.de
Zell
Roland
R
Martin
Ulrike
U
Stelzner
Axel
A
D000818:Animals; D000998:Antiviral Agents / Q000502:physiology*; D029822:Enterovirus B, Human / Q000235:genetics / Q000472:pathogenicity*; D004769:Enterovirus Infections / Q000517:prevention & control*; D007371:Interferon-gamma / Q000235:genetics / Q000502:physiology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D019001:Nitric Oxide Synthase / Q000235:genetics; D052247:Nitric Oxide Synthase Type II; D012333:RNA, Messenger / Q000032:analysis; D011995:Recombination, Genetic; D014779:Virus Replication
D000998:Antiviral Agents; D012333:RNA, Messenger; D007371:Interferon-gamma; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496317:Nos2 protein, mouse